Dr. Fabio Cominelli to study inflammatory bowel disease with XBiotech: 3 things to know

Austin, Texas-based XBiotech has entered a research collaboration with Fabio Cominelli, MD, PhD.

Here's what you need to know:

1. Dr. Cominelli is the chief of the division of gastroenterology and liver disease at Case Western Reserve University School of Medicine, director of the digestive health institute at Case Western Reserve University School of Medicine and chief scientific officer of the digestive health institute at University Hospitals Cleveland Medical Center, all of which are located in Cleveland.

2. XBiotech develops therapeutic antibodies for the treatment of inflammatory conditions, infectious diseases and tumors; the company's antibody therapy, for example, can be used to neutralize inflammation.

3. Dr. Cominelli's research team at Case Western Reserve University School of Medicine will conduct preclinical studies with XBiotech's antibody therapy, in an effort to develop new inflammatory bowel disease treatments.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast